Connection

Announcement

You can now add alternative names! Click here to add other names that you've published under.

Search Results to Fenghuang Zhan

This is a "connection" page, showing the details of why an item matched the keywords from your search.

Search Results

Zhan, Fenghuang

One or more keywords matched the following items that are connected to Zhan, Fenghuang

Item Type	Name
Academic Article	The role of the Wnt-signaling antagonist DKK1 in the development of osteolytic lesions in multiple myeloma.
Academic Article	Gene expression profiles of primary HPV16- and HPV18-infected early stage cervical cancers and normal cervical epithelium: identification of novel candidate molecular markers for cervical cancer diagnosis and therapy.
Academic Article	Gene expression profiles in primary ovarian serous papillary tumors and normal ovarian epithelium: identification of candidate molecular markers for ovarian cancer diagnosis and therapy.
Academic Article	The distinct gene expression profiles of chronic lymphocytic leukemia and multiple myeloma suggest different anti-apoptotic mechanisms but predict only some differences in phenotype.
Academic Article	Immunization with a recombinant MAGE-A3 protein after high-dose therapy for myeloma.
Academic Article	Frequent engagement of the classical and alternative NF-kappaB pathways by diverse genetic abnormalities in multiple myeloma.
Academic Article	CKS1B, overexpressed in aggressive disease, regulates multiple myeloma growth and survival through SKP2- and p27Kip1-dependent and -independent mechanisms.
Academic Article	Dickkopf-1 (DKK1) is a widely expressed and potent tumor-associated antigen in multiple myeloma.
Academic Article	Progress in myeloma stem cells.
Academic Article	Fibroblast activation protein (FAP) is upregulated in myelomatous bone and supports myeloma cell survival.
Academic Article	Gene expression profiling defines a high-risk entity of multiple myeloma.
Academic Article	The molecular classification of multiple myeloma.
Academic Article	Over-expression of CKS1B activates both MEK/ERK and JAK/STAT3 signaling pathways and promotes myeloma cell drug-resistance.
Academic Article	CS1, a potential new therapeutic antibody target for the treatment of multiple myeloma.
Academic Article	Clinical, immunophenotypic, and genetic characterization of small lymphocyte-like plasma cell myeloma: a potential mimic of mature B-cell lymphoma.
Academic Article	Arsenic trioxide-mediated growth inhibition of myeloma cells is associated with an extrinsic or intrinsic signaling pathway through activation of TRAIL or TRAIL receptor 2.
Academic Article	High expression of BCL3 in human myeloma cells is associated with increased proliferation and inferior prognosis.
Academic Article	NY-ESO-1 is highly expressed in poor-prognosis multiple myeloma and induces spontaneous humoral and cellular immune responses.
Academic Article	The oxidative stress response regulates DKK1 expression through the JNK signaling cascade in multiple myeloma plasma cells.
Academic Article	Overexpression and involvement in migration by the metastasis-associated phosphatase PRL-3 in human myeloma cells.
Academic Article	Identification of early growth response protein 1 (EGR-1) as a novel target for JUN-induced apoptosis in multiple myeloma.
Academic Article	RARalpha2 expression is associated with disease progression and plays a crucial role in efficacy of ATRA treatment in myeloma.
Academic Article	Global gene expression profiling of multiple myeloma, monoclonal gammopathy of undetermined significance, and normal bone marrow plasma cells.
Concept	B-Lymphocytes
Concept	Clone Cells
Concept	Cells, Cultured
Concept	Dendritic Cells
Concept	Bone Marrow Cells
Concept	Myeloid Progenitor Cells
Concept	Jurkat Cells
Concept	HCT116 Cells
Concept	Plasma Cells
Concept	CD8-Positive T-Lymphocytes
Concept	HEK293 Cells
Concept	Endothelial Cells
Concept	Side-Population Cells
Concept	Killer Cells, Natural
Concept	Lymphocytes
Concept	Stem Cells
Concept	Tumor Cells, Cultured
Concept	T-Lymphocytes
Concept	K562 Cells
Concept	Neoplastic Stem Cells
Concept	T-Lymphocytes, Cytotoxic
Academic Article	Gene expression profiling of plasma cells and plasmablasts: toward a better understanding of the late stages of B-cell differentiation.
Academic Article	CD27 is heterogeneously expressed in multiple myeloma: low CD27 expression in patients with high-risk disease.
Academic Article	Generation of polyclonal plasmablasts from peripheral blood B cells: a normal counterpart of malignant plasmablasts.
Academic Article	Drug resistance in hematologic malignancies: induction mechanisms, genetics, and therapeutics.
Grant	Gene expression profiling vs MRD assessment in Myeloma
Academic Article	Bruton tyrosine kinase is a therapeutic target in stem-like cells from multiple myeloma.
Academic Article	Gene Expression Profiling Reveals Aberrant T-cell Marker Expression on Tumor Cells of Waldenstr?m's Macroglobulinemia.
Academic Article	Cancer stem cells are the cause of drug resistance in multiple myeloma: fact or fiction?
Academic Article	Multiple Myeloma Tumor Cells are Selectively Killed by Pharmacologically-dosed Ascorbic Acid.
Academic Article	RARa2 expression confers myeloma stem cell features.
Academic Article	Preclinical validation of interleukin 6 as a therapeutic target in multiple myeloma.
Academic Article	A human ICAM-1 antibody isolated by a function-first approach has potent macrophage-dependent antimyeloma activity in vivo.
Academic Article	Nek2 is a novel regulator of B cell development and immunological response.
Academic Article	Identification and Characterization of Tumor-Initiating Cells in Multiple Myeloma.
Academic Article	A Small-Molecule Inhibitor Targeting TRIP13 Suppresses Multiple Myeloma Progression.
Academic Article	Neoplastic plasma cell aberrant antigen expression patterns and their association with genetic abnormalities.
Academic Article	Ferroportin downregulation promotes cell proliferation by modulating the Nrf2-miR-17-5p axis in multiple myeloma.
Academic Article	Chimeric antigen receptor T cell therapies for multiple myeloma.
Academic Article	[Myeloma cancer stem cells:the new target for multiple myeloma].
Academic Article	Carfilzomib enhances natural killer cell-mediated lysis of myeloma linked with decreasing expression of HLA class I.
Academic Article	Antitumor activity of fucoidan against diffuse large B cell lymphoma in vitro and in vivo.
Academic Article	Down-regulation of 11?-hydroxysteroid dehydrogenase type 2 by bortezomib sensitizes Jurkat leukemia T cells against glucocorticoid-induced apoptosis.
Academic Article	Overexpression of RPS27a contributes to enhanced chemoresistance of CML cells to imatinib by the transactivated STAT3.
Academic Article	Proteasome inhibitor lactacystin augments natural killer cell cytotoxicity of myeloma via downregulation of HLA class I.
Academic Article	Bortezomib resistance can be reversed by induced expression of plasma cell maturation markers in a mouse in vitro model of multiple myeloma.
Academic Article	Chromosome 1q21 gains confer inferior outcomes in multiple myeloma treated with bortezomib but copy number variation and percentage of plasma cells involved have no additional prognostic value.
Academic Article	Myeloma cells resistance to NK cell lysis mainly involves an HLA class I-dependent mechanism.
Academic Article	Mitochondrial-Targeted Decyl-Triphenylphosphonium Enhances 2-Deoxy-D-Glucose Mediated Oxidative Stress and Clonogenic Killing of Multiple Myeloma Cells.
Academic Article	Proteasome inhibitor carfilzomib interacts synergistically with histone deacetylase inhibitor vorinostat in Jurkat T-leukemia cells.
Grant	Retinoid Based Treatment Approaches to Target the Myeloma Stem Cell
Grant	NEK2 Over-expression Causes Drug Resistance in Myeloma
Academic Article	Catalyst-Free One-Pot Synthesis of Densely Substituted Pyrazole-Pyrazines as Anti-Colorectal Cancer Agents.
Academic Article	RFWD2 induces cellular proliferation and selective proteasome inhibitor resistance by mediating P27 ubiquitination in multiple myeloma.
Academic Article	The molecular make up of smoldering myeloma highlights the evolutionary pathways leading to multiple myeloma.
Grant	Targeting NEK2 Enables Immune Checkpoint Blockade in High-Risk/Relapsed Myeloma
Academic Article	TRIP13 modulates protein deubiquitination and accelerates tumor development and progression of B cell malignancies.
Academic Article	Geographic and Racial Disparities in Access to Chimeric Antigen Receptor-T Cells and Bispecific Antibodies Trials for Multiple Myeloma.
Academic Article	A gene signature can predict risk of MGUS progressing to multiple myeloma.
Academic Article	AKT supports the metabolic fitness of multiple myeloma cells by?restricting FOXO activity.
Academic Article	BCMA- and CST6-specific CAR T cells lyse multiple myeloma cells and suppress murine osteolytic lesions.
Academic Article	High NEK2 expression in myeloid progenitors suppresses T?cell immunity in multiple myeloma.
Academic Article	Bispecific BCMA/CD24 CAR-T cells control multiple myeloma growth.
Academic Article	Enhancing prognostic power in multiple myeloma using a plasma cell signature derived from single-cell RNA sequencing.

Search Criteria

T Lymphocytes